对于 CD4+T 淋巴细胞计数>=300 个/μL 且 HIV-1 得到抑制的患者，是否需要频繁进行 CD4+T 淋巴细胞计数监测？
Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?
机构信息
Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA.
出版信息
Clin Infect Dis. 2013 May;56(9):1340-3. doi: 10.1093/cid/cit004. Epub 2013 Jan 11.
Abstract
Among patients infected with human immunodeficiency virus (HIV), those with HIV-1 RNA <200 copies/mL and CD4 counts ≥300 cells/µL had a 97.1% probability of maintaining durable CD4 ≥200 cells/µL for 4 years. When non-HIV causes of CD4 lymphopenia were excluded, the probability rose to 99.2%. Our data support less frequent CD4 monitoring during viral suppression.
摘要
在感染人类免疫缺陷病毒 (HIV) 的患者中，那些 HIV-1 RNA <200 拷贝/毫升且 CD4 计数≥300 个/微升的患者，有 97.1%的概率在 4 年内维持持久的 CD4 ≥200 个/微升。当排除非 HIV 导致的 CD4 淋巴细胞减少症的原因时，这一概率上升至 99.2%。我们的数据支持在病毒抑制期间减少 CD4 监测的频率。
相似文献
1
Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?对于 CD4+T 淋巴细胞计数>=300 个/μL 且 HIV-1 得到抑制的患者，是否需要频繁进行 CD4+T 淋巴细胞计数监测？
Clin Infect Dis. 2013 May;56(9):1340-3. doi: 10.1093/cid/cit004. Epub 2013 Jan 11.
2
Routine CD4 monitoring in HIV patients with viral suppression: Is it really necessary? A Portuguese cohort.HIV 患者病毒抑制后常规 CD4 监测是否真的必要？葡萄牙队列研究
J Microbiol Immunol Infect. 2018 Oct;51(5):593-597. doi: 10.1016/j.jmii.2016.09.003. Epub 2017 Jun 22.
3
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.在接受高效抗逆转录病毒治疗并实现持续病毒学抑制的患者中，治疗开始6年后的CD4 +细胞计数。
Clin Infect Dis. 2007 Feb 1;44(3):441-6. doi: 10.1086/510746. Epub 2006 Dec 20.
4
Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?对于接受抗反转录病毒治疗后 HIV-1 RNA 得到抑制的患者，我们能否停止进行 CD4+ 细胞检测？
AIDS. 2013 Nov 13;27(17):2759-63. doi: 10.1097/01.aids.0000432458.98851.c1.
5
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.基于高收入国家中接受联合抗逆转录病毒治疗的病毒抑制、HIV 阳性个体的 CD4 细胞计数的动态监测策略比较：一项前瞻性观察研究。
Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.
6
Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.接受联合抗逆转录病毒治疗的泰国患者免疫和病毒学终点的预测因素。
HIV Med. 2007 Jan;8(1):46-54. doi: 10.1111/j.1468-1293.2007.00427.x.
7
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.接受强效抗逆转录病毒治疗4年的晚期HIV-1感染个体的CD4 T淋巴细胞恢复情况：瑞士HIV队列研究
Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187.
8
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.接受抗逆转录病毒治疗且病毒抑制达4年的HIV感染成人，其CD4细胞计数持续增加。
AIDS. 2003 Sep 5;17(13):1907-15. doi: 10.1097/00002030-200309050-00009.
9
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.基线病毒载量和依从性对基线CD4细胞计数≥200个/微升的HIV感染成人存活率的影响。
AIDS. 2006 May 12;20(8):1117-23. doi: 10.1097/01.aids.0000226951.49353.ed.
10
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.启动三联药物治疗后，按基线CD4细胞计数和病毒载量划分的疾病进展率。
JAMA. 2001 Nov 28;286(20):2568-77. doi: 10.1001/jama.286.20.2568.
引用本文的文献
1
Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016.国际艾滋病流行病学数据库评估艾滋病全球艾滋病毒队列合作组织，2000-2016 年，成人艾滋病毒感染者个体临床保留与关怀的地点层面综合性相关。
AIDS Patient Care STDS. 2022 Sep;36(9):343-355. doi: 10.1089/apc.2022.0042. Epub 2022 Aug 26.
2
Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.布基纳法索开始抗逆转录病毒疗法的女性性工作者中的免疫病毒学不一致性。
BMC Infect Dis. 2022 Feb 3;22(1):117. doi: 10.1186/s12879-022-07109-8.
3
Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.在普遍开展抗逆转录病毒治疗的时代，CD4 计数检测的实用性：博茨瓦纳常规实验室数据的分析。
HIV Med. 2021 Jan;22(1):1-10. doi: 10.1111/hiv.12951. Epub 2020 Sep 2.
4
Is it Safe and Cost Saving to Defer the CD4+ Cell Count Monitoring in Stable Patients on Art with More than 350 or 500 cells/μl?对于接受抗逆转录病毒治疗且CD4+细胞计数超过350或500个/μl的病情稳定患者，推迟CD4+细胞计数监测是否安全且节省成本？
Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019063. doi: 10.4084/MJHID.2019.063. eCollection 2019.
5
CD8 T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy.抗逆转录病毒治疗时代的 HIV 感染中的 CD8 T 细胞反应。
Front Immunol. 2019 Aug 9;10:1896. doi: 10.3389/fimmu.2019.01896. eCollection 2019.
6
Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment.沙特阿拉伯艾滋病毒感染患者抗逆转录病毒治疗成功后免疫重建欠佳
Can J Infect Dis Med Microbiol. 2019 Jan 10;2019:1842106. doi: 10.1155/2019/1842106. eCollection 2019.
7
Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview.资源有限环境下的 HIV 即时诊断检测：概述。
Medicina (Kaunas). 2018 Mar 13;54(1):3. doi: 10.3390/medicina54010003.
8
Homozygous deletion of both GSTM1 and GSTT1 genes is associated with higher CD4+ T cell counts in Ghanaian HIV patients.在加纳的 HIV 患者中，GSTM1 和 GSTT1 基因的纯合缺失与较高的 CD4+T 细胞计数相关。
PLoS One. 2018 May 24;13(5):e0195954. doi: 10.1371/journal.pone.0195954. eCollection 2018.
9
CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto System.CD4淋巴细胞计数与血红蛋白评估助力优先决策：BD FACSPresto系统的多中心评估
Open AIDS J. 2017 Oct 24;11:76-90. doi: 10.2174/1874613601711010076. eCollection 2017.
10
Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.越南艾滋病毒/艾滋病患者抗逆转录病毒治疗过程中病毒载量监测的共同融资：一项条件价值评估调查。
PLoS One. 2017 Feb 15;12(2):e0172050. doi: 10.1371/journal.pone.0172050. eCollection 2017.
本文引用的文献
1
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?对于病毒学抑制的 HIV 感染且 CD4 细胞计数<200 个/μL 的患者，停止原发性卡氏肺孢子虫肺炎预防是否安全？
Clin Infect Dis. 2010 Sep 1;51(5):611-9. doi: 10.1086/655761.
2
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.CD4+ 细胞计数在病毒载量抑制期间的增加率：与之前病毒学失败次数的关系。
Clin Infect Dis. 2010 Aug 15;51(4):456-64. doi: 10.1086/655151.
3
CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection.1型人类免疫缺陷病毒感染个体的CD4 + T淋巴细胞恢复情况。
Clin Infect Dis. 2010 Aug 15;51(4):465-7. doi: 10.1086/655152.
4
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.《HIV 感染成人及青少年机会性感染的预防与治疗指南：美国疾病控制与预防中心、国立卫生研究院及美国传染病学会 HIV 医学协会的建议》
MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4.
5
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.开始高效抗逆转录病毒治疗的HIV-1感染患者的预后：前瞻性研究的协作分析
Lancet. 2002 Jul 13;360(9327):119-29. doi: 10.1016/s0140-6736(02)09411-4.
6
Product-limit survival functions with correlated survival times.具有相关生存时间的乘积限生存函数。
Lifetime Data Anal. 1995;1(2):171-86. doi: 10.1007/BF00985768.
7
T-lymphocyte subsets in acute illness.急性疾病中的T淋巴细胞亚群。
Crit Care Med. 1995 Oct;23(10):1680-5. doi: 10.1097/00003246-199510000-00012.
8
Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals.对临床稳定的HIV感染者CD4淋巴细胞计数中实验室和生理来源导致的变异进行量化。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S67-73.
Zotero 插件